iBio, Inc. Common Stock

IBIONASDAQ • USD
ThemeAI & Machine Learning›AI-Powered Analytics & Decision Systems
1.43 USD
↘ 0.05 (3.06%)🟢LIVE (AS OF 02:54 PM EDT)
🟢Market: OPEN
Open?$1.49
High?$1.50
Low?$1.43
Prev. Close?$1.47
Volume?452.4K
Avg. Volume?898.5K
VWAP?$1.46
Rel. Volume?0.50x
Bid / Ask
Bid?$1.42 × 600
Ask?$1.44 × 1.3K
Spread?$0.02
Midpoint?$1.43
Valuation & Ratios
Market Cap?73.0M
Shares Out?49.7M
Float?31.5M
Float %?91.3%
P/E Ratio?N/A
P/B Ratio?0.94
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Themes
AI & Machine Learning›AI-Powered Analytics & Decision SystemsBiotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
20
Market Cap
73.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ibioinc.com
Listed
2008-08-19
Address
600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
Phone: 302 355-0650
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.88Strong
Quick Ratio?11.88Strong
Cash Ratio?7.32Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A▾
P/B?
0.94CHEAP▾
P/S?
243.42HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
-1.3CHEAP▾
EV/Sales?
84.65HIGH▾
Returns & Efficiency
ROE?
-24.1%WEAK▾
ROA?
-21.7%WEAK▾
Cash Flow & Enterprise
FCF?$-22181000
Enterprise Value?$25.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist